JPMorgan Chase & Co’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.65M | Sell |
478,263
-174,456
| -27% | -$2.79M | ﹤0.01% | 2397 |
|
|
2025
Q1 | $11.2M | Sell |
652,719
-500,619
| -43% | -$8.56M | ﹤0.01% | 2103 |
|
|
2024
Q4 | $28.6M | Buy |
1,153,338
+925,081
| +405% | +$22.9M | ﹤0.01% | 1485 |
|
|
2024
Q3 | $6.51M | Sell |
228,257
-28,586
| -11% | -$815K | ﹤0.01% | 2472 |
|
|
2024
Q2 | $6.78M | Buy |
256,843
+11,810
| +5% | +$312K | ﹤0.01% | 2348 |
|
|
2024
Q1 | $7.92M | Sell |
245,033
-225,957
| -48% | -$7.3M | ﹤0.01% | 2278 |
|
|
2023
Q4 | $19.8M | Buy |
470,990
+42,482
| +10% | +$1.79M | ﹤0.01% | 1645 |
|
|
2023
Q3 | $16.5M | Sell |
428,508
-14,001
| -3% | -$537K | ﹤0.01% | 1640 |
|
|
2023
Q2 | $8.39M | Buy |
442,509
+380,517
| +614% | +$7.22M | ﹤0.01% | 2156 |
|
|
2023
Q1 | $961K | Buy |
61,992
+11,578
| +23% | +$179K | ﹤0.01% | 3470 |
|
|
2022
Q4 | $895K | Sell |
50,414
-112,794
| -69% | -$2M | ﹤0.01% | 3423 |
|
|
2022
Q3 | $911K | Sell |
163,208
-489,973
| -75% | -$2.73M | ﹤0.01% | 3415 |
|
|
2022
Q2 | $2.55M | Buy |
653,181
+191,599
| +42% | +$747K | ﹤0.01% | 2846 |
|
|
2022
Q1 | $2.54M | Buy |
461,582
+310,520
| +206% | +$1.71M | ﹤0.01% | 3018 |
|
|
2021
Q4 | $1.29M | Sell |
151,062
-207,731
| -58% | -$1.77M | ﹤0.01% | 3517 |
|
|
2021
Q3 | $3.12M | Buy |
358,793
+328,156
| +1,071% | +$2.85M | ﹤0.01% | 2890 |
|
|
2021
Q2 | $324K | Buy |
30,637
+5,378
| +21% | +$56.9K | ﹤0.01% | 4239 |
|
|
2021
Q1 | $406K | Buy |
25,259
+4,384
| +21% | +$70.5K | ﹤0.01% | 4156 |
|
|
2020
Q4 | $964K | Buy |
20,875
+3,656
| +21% | +$169K | ﹤0.01% | 3405 |
|
|
2020
Q3 | $627K | Buy |
17,219
+1,142
| +7% | +$41.6K | ﹤0.01% | 3292 |
|
|
2020
Q2 | $392K | Buy |
16,077
+13,169
| +453% | +$321K | ﹤0.01% | 3389 |
|
|
2020
Q1 | $45K | Buy |
+2,908
| New | +$45K | ﹤0.01% | 4167 |
|